M2-like tumor-associated macrophage-secreted CCL2 facilitates gallbladder cancer stemness and metastasis
Experimental Hematology & Oncology · 13.08.2024 · 13 (1)
DOI: 10.1186/s40164-024-00550-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental Hematology & Oncology, online erschienen am 13.08.2024. Verfasst von Weihong Chen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary Surgery, Fujian Institute of Hepatobiliary Surgery, Fujian Medical University Union Hospital, Fuzhou, 350001, Fujian, Chi…. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Startup Fund for Scientific Research, Fujian Medical University, Science and Technology Innovation Joint Foundation of Fujian Province, High-Level Medical Care Construction Foundation of Fujian Province.
Abstract (Originalsprache)
Background
The predominant immune cells in solid tumors are M2-like tumor-associated macrophages (M2-like TAMs), which significantly impact the promotion of epithelial-mesenchymal transition (EMT) in tumors, enhancing stemness and facilitating tumor invasion and metastasis. However, the contribution of M2-like TAMs to tumor progression in gallbladder cancer (GBC) is partially known.
Methods
Immunohistochemistry was used to evaluate the expression of M2-like TAMs and cancer stem cell (CSC) markers in 24 pairs of GBC and adjacent noncancerous tissues from patients with GBC. Subsequently, GBC cells and M2-like TAMs were co-cultured to examine the expression of CSC markers, EMT markers, and migratory behavior. Proteomics was performed on the culture supernatant of M2-like TAMs. The mechanisms underlying the induction of EMT, stemness, and metastasis in GBC by M2-like TAMs were elucidated using proteomics and transcriptomics. GBC cells were co-cultured with undifferentiated macrophages (M0) and analyzed. The therapeutic effect of gemcitabine combined with a chemokine (C-C motif) receptor 2 (CCR2) antagonist on GBC was observed in vivo.
Results
The expression levels of CD68 and CD163 in M2-like TAMs and CD44 and CD133 in gallbladder cancer stem cells (GBCSCs) were increased and positively correlated in GBC tissues compared with those in neighboring noncancerous tissues. M2-like TAMs secreted a significant amount of chemotactic cytokine ligand 2 (CCL2), which activated the MEK/extracellular regulated protein kinase (ERK) pathway and enhanced SNAIL expression after binding to the receptor CCR2 on GBC cells. Activation of the ERK pathway caused nuclear translocation of ELK1, which subsequently led to increased SNAIL expression. GBCSCs mediated the recruitment and polarization of M0 into M2-like TAMs within the GBC microenvironment via CCL2 secretion. In the murine models, the combination of a CCR2 antagonist and gemcitabine efficiently inhibited the growth of subcutaneous tumors in GBC.
Conclusions
The interaction between M2-like TAMs and GBC cells is mediated by the chemokine CCL2, which activates the MEK/ERK/ELK1/SNAIL pathway in GBC cells, promoting EMT, stemness, and metastasis. A combination of a CCR2 inhibitor and gemcitabine effectively suppressed the growth of subcutaneous tumors. Consequently, our study identified promising therapeutic targets and strategies for treating GBC.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hepatobiliary Surgery, Fujian Institute of Hepatobiliary Surgery, Fujian Medical University Union Hospital, Fuzhou, 350001, Fujian, China.
- Fujian Medical University Cancer Center, Fuzhou, 350108, China.
- Key Laboratory of Ministry of Education for Gastrointestinal Cancer, Fujian Medical University, Fuzhou, 350108, China.
- Fujian Key Laboratory of Tumor Microbiology, Department of Medical Microbiology, Fujian Medical University, Fuzhou, 350108, Fujian, China.
- Key Laboratory of Ministry of Education for Gastrointestinal Cancer, Fujian Medical University, Fuzhou, 350108, China. shefeifei@yeah.net.
- Fujian Key Laboratory of Tumor Microbiology, Department of Medical Microbiology, Fujian Medical University, Fuzhou, 350108, Fujian, China. shefeifei@yeah.net.
Förderung
- Startup Fund for Scientific Research, Fujian Medical University
- Science and Technology Innovation Joint Foundation of Fujian Province
- High-Level Medical Care Construction Foundation of Fujian Province
Zitieren
APA
Chen, W., Chen, M., Hong, L., Xiahenazi, A., Huang, M., Tang, N., Yang, X., She, F., & Chen, Y. (2024). M2-like tumor-associated macrophage-secreted CCL2 facilitates gallbladder cancer stemness and metastasis. Experimental Hematology & Oncology, 13(1). https://doi.org/10.1186/s40164-024-00550-2
Vancouver
Chen W, Chen M, Hong L, Xiahenazi A, Huang M, Tang N, et al. M2-like tumor-associated macrophage-secreted CCL2 facilitates gallbladder cancer stemness and metastasis. Experimental Hematology & Oncology. 2024;13(1). doi:10.1186/s40164-024-00550-2
BibTeX
@article{Chen2024,
author = {Chen, Weihong and Chen, Mingyuan and Hong, Lingju and Xiahenazi, Abudukeremu and Huang, Maotuan and Tang, Nanhong and Yang, Xinyue and She, Feifei and Chen, Yanling},
title = {M2-like tumor-associated macrophage-secreted CCL2 facilitates gallbladder cancer stemness and metastasis},
journal = {Experimental Hematology & Oncology},
year = {2024},
volume = {13},
number = {1},
doi = {10.1186/s40164-024-00550-2}
}
EUVIMED